Log In
BCIQ
Print this Print this
 

BSI-401

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSecond-generation poly(ADP-ribose) polymerase (PARP) inhibitor
Molecular Target Poly(ADP-ribose) polymerase (PARP)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$500.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/27/2009

$500.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today